Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02081248 · ClinicalTrials.gov registry record · NA
Easy-to-Read Informed Consent (ETRIC) for Hematopoietic Cell Transplantation Clinical Trials (BMT CTN 1205)
A NA study of Improve the Informed Consent Process, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 198
- Enrollment target
- 20
- Study locations
NCT02081248 is a NA study of Improve the Informed Consent Process that has completed, run by Medical College of Wisconsin. The registered enrollment target is 198 participants. The trial reports 20 study locations across 12 states.
The verdict
NCT02081248, a NA study of Improve the Informed Consent Process, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 198 participants
- Enrollment target
- 20
- Study locations
Study Summary
The study has two parts: (1) Randomized Study to evaluate the effectiveness of ETRIC, and (2) Evaluation Study to understand barriers to implementation of ETRIC.
Conditions Studied
Interventions
- OTHER Consent Form Specific Format 1
- OTHER Consent Form Specific Format 2
Study Locations (20)
Ohio
- The Jewish Hospital BMT Program - Cincinnati
- University Hospitals of Cleveland/Case Western - Cleveland
- Cleveland Clinic Foundation - Cleveland
- Ohio State/Arthur G. James Cancer Hospital - Columbus
Florida
- University of Florida College of Medicine (Shands) - Gainesville
- Florida Hospital Cancer Institute - Orlando
- H. Lee Moffitt Cancer Center - Tampa
Georgia
- Emory University - Atlanta
- BMT Program at Northside Hospital - Atlanta
Minnesota
- University of Minnesota - Minneapolis
- Mayo Clinic - Rochester - Rochester
North Carolina
- University of North Carolina Hospital at Chapel Hill - Chapel Hill
- Duke University Medical Center - Durham
California
- City of Hope National Medical Center - Duarte
Illinois
- Loyola University Medical Center - Maywood
Kansas
- University of Kansas - Lawrence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2013-12 |
| Est. Completion | 2016-08-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02081248
The ClinicalTrials.gov registry entry for NCT02081248 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Improve the Informed Consent Process appearing as the primary indexed condition, and to 2 interventions - of which Consent Form Specific Format 1 is the first listed.
NCT02081248 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Ohio, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT02081248 about?
NCT02081248 is a clinical study titled "Easy-to-Read Informed Consent (ETRIC) for Hematopoietic Cell Transplantation Clinical Trials (BMT CTN 1205)". The study has two parts: (1) Randomized Study to evaluate the effectiveness of ETRIC, and (2) Evaluation Study to understand barriers to implementation of ETRIC.
What is the current status of trial NCT02081248?
This trial is currently completed. It is a NA study. The enrollment target is 198 participants. The study started on 2013-12. Estimated completion is 2016-08-03.
What conditions does trial NCT02081248 study?
This clinical trial studies the following conditions: Improve the Informed Consent Process.
What interventions are being tested in trial NCT02081248?
The interventions under investigation include: Consent Form Specific Format 1 (OTHER), Consent Form Specific Format 2 (OTHER).
Who is sponsoring clinical trial NCT02081248?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02081248 being conducted?
This trial has 20 study locations across California, Florida, Georgia, Illinois, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.